Document ID: chunk:federal_register_of_legislation:F2018L01746:clause:2_18
Version: federal_register_of_legislation:F2018L01746
Segment Type: clause
Provision Reference: sch 2 cl 18
Character Range: 37337–38448

18                                       updated                                     date that the entry was last updated

  In this Part:
  low impact, in relation to a discontinuation of a supply of a medicine that is not of critical impact, means a discontinuation that is assessed as low patient impact in accordance with the assessment framework set out in the Medicine Shortages Information Initiative: Protocol for all Australian Sponsors and the Therapeutic Goods Administration published in May 2014.
  medium impact, in relation to a discontinuation of a supply of a  medicine that is not of critical impact, means a discontinuation that is assessed as low patient impact in accordance with the assessment framework set out in the Medicine Shortages Information Initiative: Protocol for all Australian Sponsors and the Therapeutic Goods Administration published in May 2014.
Note:  The Medicine Shortages Information Initiative: Protocol for all Australian Sponsors and the Therapeutic Goods Administration can be found on the internet (and viewed for free) on the internet at: http://www.tga.gov.au.